Viewing Study NCT02581995


Ignite Creation Date: 2025-12-24 @ 2:10 PM
Ignite Modification Date: 2026-02-23 @ 9:22 PM
Study NCT ID: NCT02581995
Status: COMPLETED
Last Update Posted: 2018-10-10
First Post: 2015-10-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Investigation of the Change of Vision-related Quality of Life in Subjects Treated With Aflibercept According to EU Label for DME.
Sponsor: Bayer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Macular Edema View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetic macular edema View
None Intravitreal injection View